SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001182489-15-000542
Filing Date
2015-05-20
Accepted
2015-05-20 11:53:18
Documents
1
Period of Report
2015-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 12153
  Complete submission text file 0001182489-15-000542.txt   13753
Mailing Address C/O FARALLON CAPITAL MANAGEMENT, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address
PATEL RAJIV A (Reporting) CIK: 0001275110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36828 | Film No.: 15878717

Mailing Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000
Business Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000 353 1 215 8100
Nexvet Biopharma plc (Issuer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations